On the 7th of August 2014, Tekmira Pharmaceuticals Announced That the FDA has Allowed Potential Use of Their Experimental Ebola Drug on Infected Patients

FDA Enables Potential Use of Experimental Tekmira Vaccine on Ebola Patients

On the 7th of August 2014, Tekmira Pharmaceuticals Announced That the FDA has Allowed Potential Use of Their Experimental Ebola Drug on Infected Patients The FDA has lifted a temporary ‘halt in research’ placed on the Ebola drug that has been┬ádeveloped by Canadian company Tekmira Pharmaceuticals. The lift of this hold means that the experimental drug may potentially be used …